Dr. Guru Sonpavde joins the Bladder Cancer Matters podcast to discuss different types of chemotherapy as well as alternative options.
Episode 15 of the Bladder Cancer Matters podcast is about a challenge facing many bladder cancer survivors: some patients cannot get chemotherapy to treat their bladder cancer. Its special guest is Dr. Guru Sonpavde, the Bladder Cancer Director at the Dana-Farber Cancer Institute in Boston.
At Dana-Farber, Dr. Sonpavde leads multiple cutting-edge clinical trials studying novel immunotherapy and targeted drugs to cure bladder cancer. He is the also the national or international Principal Investigator of multiple clinical trials of bladder cancer patients. Additionally, he is a member of the BCAN Scientific Advisory Board.
In this podcast, Rick and Dr. Sonpavde discuss:
Never miss an episode by subscribing to BCAN's podcast. Simply search for “Bladder Cancer Matters” on your favorite podcast application and click the “subscribe” button.
You can follow Dr. Sonpavde on Twitter using his handle, @Sonpavde.